FAKTOR OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Stock

Certificat

DE000PX2FMS5

Market Closed - Börse Stuttgart 11:29:12 2024-06-25 EDT
6.97 EUR +4.19% Intraday chart for FAKTOR OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month+18.14%
1 month+16.75%
Date Price Change
24-06-25 6.97 +4.19%
24-06-24 6.69 -6.69%
24-06-21 7.17 +6.54%
24-06-20 6.73 -1.90%
24-06-19 6.86 +3.00%

Delayed Quote Börse Stuttgart

Last update June 25, 2024 at 11:29 am

More quotes

Static data

Product typeExotische Produkte
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PX2FMS
ISINDE000PX2FMS5
Date issued 2018-12-05
Strike 36.35
Maturity Unlimited
Parity 0.11 : 1
Emission price 10
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 24.05
Lowest since issue 5.15
Spread 0.15
Spread %2.13%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.67 EUR
Average target price
39.97 EUR
Spread / Average Target
+12.07%
Consensus